PositiveID Corporation (fka PSID)

[AMOTE1]

PositiveID Corporation's Thermomedics' Subsidiary Signs Deals with Five New Healthcare Products Distributors in January
PR Newswire PositiveID Corporation
5 minutes ago

????

DELRAY BEACH, Florida, February 11, 2016 /PRNewswire/ --

PositiveID Corporation ("PositiveID" or "Company") (PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary, which markets the Caregiver® FDA-cleared non-contact thermometer, made significant progress on its growth plan in January 2016, including entering into agreements with five new healthcare products distributors, increasing sequential monthly sales growth, and establishing several near-term pipeline opportunities.

Thermomedics' Caregiver thermometer is targeting the fastest growing segment of the global temperature monitoring device market, estimated at $1 billion by 2020. Caregiver is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in 1-2 seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs.

It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone. Other methods of clinical thermometry, which include predictive oral/rectal/axillary electronic, infrared tympanic, temporal artery contact scanner, etc., may require expensive protective probe covers, intensive technique concentration, which make them prone to mistaken placement or dwell time, and many have the potential to need replacement metal probes, cords, or other parts.

"January 2016 was the first full month of Thermomedics operations under PositiveID's management control," stated William J. Caragol, Chairman and CEO of PositiveID. "We already see that by better capitalizing the business, entering into new distribution agreements, managing inventory, and planning for the future, we can generate immediate results in this business operationally and financially. We expect Caregiver to be an important contributor to PositiveID's 2016 total revenues, and with extremely attractive gross margins for this product we are looking to ramp Caregiver sales as quickly as possible."

Caregiver is the world's first non-contact thermometer with TouchFree™ technology and was developed by the inventors of tympanic thermometry, who continue to lead the sales effort for Caregiver. The Company markets and sells the Caregiver thermometer primarily through healthcare products distributors.
Related Quotes

PSID0.0163+6.54%

PositiveID Corporation
Watchlist
0.0163+0.0010(6.54%)
OTC MarketsWed, Feb 10, 2016 3:58 PM EST

POSITIVEID CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securitie EDGAR Online 12 days ago
POSITIVEID CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online 27 days ago

More

The global market for temperature monitoring devices is forecast to reach $1 billion by 2020, with infrared thermometers experiencing the fastest growth driven in part by concerns over the spread of highly infectious diseases like Ebola, according to Global Industry Analysts, Inc.

About PositiveID Corporation

PositiveID Corporation is a life sciences company focused on detection and diagnostics, with an extensive patent portfolio. PositiveID specializes in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.